Decrements in Volume of Anterior Ventromedial Temporal Lobe and Olfactory Dysfunction in Schizophrenia

Archives of General Psychiatry

Volumn 60, Issue 12, 2003, Pages 1193-1200

  Turetsky, Bruce I ^a,b   Moberg, Paul J ^a   Roalf, David R ^a   Arnold, Steven E ^a   Gur, Raquel E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; COHORT ANALYSIS; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY BULB; PERCEPTIVE THRESHOLD; SCHIZOPHRENIA; SMELLING; SPATIAL MEMORY; TEMPORAL LOBE; VERBAL MEMORY;

ADOLESCENT; ADULT; ATROPHY; DOMINANCE, CEREBRAL; ENTORHINAL CORTEX; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MATHEMATICAL COMPUTING; MIDDLE AGED; OLFACTION DISORDERS; OLFACTORY BULB; OLFACTORY PATHWAYS; REFERENCE VALUES; SCHIZOPHRENIA; SENSORY THRESHOLDS; TEMPORAL LOBE;

EID: 0345167955     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.12.1193     Document Type: Article

References (67)

1. Moberg PJ, Agrin R, Gur RE, Gur RC, Turetsky BI, Doty RL. Olfactory dysfunction in schizophrenia: a qualitative and quantitative review. Neuropsychopharmacology. 1999;21:325-340.
2. Kopala LC, Clark C, Hurwitz T. Olfactory deficits in neuroleptic naive patients with schizophrenia. Schizophr Res. 1993;8:245-250.
3. Turetsky BI, Moberg BJ, Arnold SA, Doty RL, Gur RE. Low olfactory bulb volume in first-degree relatives of patients with schizophrenia. Am J Psychiatry. 2003;160:703-708.
4. Turetsky BI, Moberg PJ, Yousem DM, Doty RL, Arnold SE, Gur RE. Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry. 2000;157:828-830.
5. Insausti R, Juottonen K, Soininen H, Insausti AM, Partanen K, Vainio P, Laakso MP, Pitkanen A. MR volumetric analysis of the human entorhinal, perirhinal, and temporopolar cortices. AJNR Am J Neuroradiol. 1998;19:659-671.
6. Saykin AJ, Shtasel DL, Gur RE, Kester DB, Mozley LH, Stafiniak P, Gur RC. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 1994;51:124-131.
7. Saykin AJ, Gur RC, Gur RE, Mozley PD, Mozley LH, Resnick SM, Kester DB, Stafiniak P. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry. 1991;48:618-624.
8. Kohler CG, Bilker W, Hagendoorn M, Gur RE, Gur RC. Emotion recognition deficit in schizophrenia: association with symptomatology and cognition. Biol Psychiatry. 2000;48:127-136.
9. Habel U, Gur RC, Mandal MK, Salloum JB, Gur RE, Schneider F. Emotional processing in schizophrenia across cultures: standardized measures of discrimination and experience. Schizophr Res. 2000;42:57-66.
10. Schneider F, Gur RC, Gur RE, Shtasel DL. Emotional processing in schizophrenia: neurobehavioral probes in relation to psychopathology. Schizophr Res. 1995;17:67-75.
11. Heimberg C, Gur RE, Erwin RJ, Shtasel DL, Gur RC. Facial emotion discrimination, III: behavioral findings in schizophrenia. Psychiatry Res. 1992;42:253-265.
12. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophr Res. 2001;49:1-52.
13. DeLisi LE, Hoff AL, Schwartz JE, Shields GW, Halthore SN, Gupta SM, Henn FA, Anand AK. Brain morphology in first-episode schizophrenic-like psychotic patients: a quantitative magnetic resonance imaging study. Biol Psychiatry. 1991;29:159-175.
14. Colombo C, Abbruzzese M, Livian S, Scotti G, Locatelli M, Bonfanti A, Scarone S. Memory functions and temporal-limbic morphology in schizophrenia. Psychiatry Res. 1993;50:45-56.
15. Bilder RM, Bogerts B, Ashtari M, Wu H, Alvir JM, Jody D, Reiter G, Bell L, Lieberman JA. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia. Schizophr Res. 1995;17:47-58.
16. Nestor PG, Shenton ME, McCarley RW, Haimson J, Smith RS, O'Donnell B, Kimble M, Kikinis R, Jolesz FA. Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. Am J Psychiatry. 1993;150:1849-1855.
17. Becker T, Elmer K, Mechela B, Schneider F, Taubert S, Schroth G, Grodd W, Bartels M, Beckmann H. MRI findings in medial temporal lobe structures in schizophrenia. Eur Neuropsychopharmacol. 1990;1:83-86.
18. Blackwood DH, Youn AH, McQueen JK, Martin MJ, Roxborough HM, Muir WJ, St Clair DM, Kean DM. Magnetic resonance imaging in schizophrenia: altered brain morphology associated with P300 abnormalities and eye tracking dysfuntion. Biol Psychiatry 1991;30:753-769.
19. Dauphinais ID, DeLisi LE, Crow TJ, Alexandropoulos K, Colter N, Tuma I, Gershon ES. Reduction in temporal lobe size in siblings with schizophrenia: a magnetic resonance imaging study. Psychiatry Res. 1990;35:137-147.
20. DeLisi LE, Dauphinais ED, Gershon ES. Perinatal complications and reduced size of brain limbic structures in familial schizophrenia. Schizophr Bull. 1988;14:185-191.
21. Havermans R, Honig A, Vuurman EF, Krabbendam L, Wilmink J, Lamers T, Verheecke CJ, Jolles J, Romme MA, van Praag HM. A controlled study of temporal lobe structure volumes and P300 responses in schizophrenic patients with persistent auditory hallucinations. Schizophr Res. 1999;38:151-158.
22. Jernigan TL, Zisook S, Heaton RK, Moranville JT, Hesselink JR, Braff DL. Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry. 1991;48:881-890.
23. Kawasaki Y, Maeda Y, Urata K, Higashima M, Yamaguchi N, Suzuki M, Takashima T, Ide Y. A quantitative magnetic resonance imaging study of patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1993;242:268-272.
24. Ohnuma T, Kimura M, Takahashi T, Iwamoto N, Arai H. A magnetic resonance imaging study in first-episode disorganized-type patients with schizophrenia. Psychiatry Clin Neurosci. 1997;51:9-15.
25. Razi K, Greene KP, Sakuma M, Ge S, Kushner M, DeLisi LE. Reduction of the parahippocampal gyrus and the hippocampus in patients with chronic schizophrenia. Br J Psychiatry. 1999;174:512-519.
26. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, Feiner D, Rotrosen J, Wolkin A. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch Gen Psychiatry. 2000;57:471-480.
27. Shenton ME, Kikinis R, Jolesz FA, Polak SD, LeMay M, Wible CG, Hokama H, Martin J, Metcalf D, Coleman M, et al. Abnormalities of the left temporal lobe and thought disorder in schizophrenia: a quantitative magnetic resonance imaging study. N Engl J Med. 1992;327:604-612.
28. Staal WG, Hulshoff Pol HE, Schnack HG, Hoogendoorn ML, Jellma K, Kahn RS. Structural brain abnormalities in patients with schizophrenia and their healthy siblings. Am J Psychiatry. 2000;157:416-421.
29. Pearlson GD, Barta PE, Powers RE, Menon RR, Richards SS, Aylward EH, Federman EB, Chase GA, Petty RG, Tien AY. Ziskind-Somerfeld Research Award 1996: medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry. 1997;41:1-14.
30. Nasrallah HA, Sharma S, Olson SC. The volume of the entorhinal cortex in schizophrenia: a controlled MRI study. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:1317-1322.
31. Florencio PS, O'Driscoll GA. The medial temporal lobe and schizophrenia. McGill Med J. 1999;5:25-34.
32. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). New York: New York State Psychiatric Institute; 1986.
33. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Cannon T, Gur RC. Phenomenology and functioning in first-episode schizophrenia. Schizophr Bull. 1992;18:449-462.
34. Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-III-R-Nonpatient Version (SCID-NP). New York: New York State Psychiatric Institute; 1987.
35. Shtasel DL, Gur RE, Mozley PD, Richards J, Taleff MM, Heimberg C, Gallacher F, Gur RC. Volunteers for biomedical research: recruitment and screening of normal controls. Arch Gen Psychiatry. 1991;48:1022-1025.
36. Overall JR, Gorham DR. The Brief Psychiatric Rating Scale. J Oper Psychiatry. 1980;11:48-64.
37. Andreasen NC. The Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1983.
38. Andreasen NC. The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa; 1984.
39. Carpenter WT Jr, Heinrichs DW, Wagman AW. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145:578-583.
40. Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, Bilker WB, Gur RC. Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia. Arch Gen Psychiatry. 2000;57:761-768.
41. Gur RE, Turetsky BI, Bilker WB, Gur RC. Reduced gray matter volume in schizophrenia. Arch Gen Psychiatry. 1999;56:905-911.
42. Gur RE, Turetsky BI, Cowell PE, Finkelman C, Maany V, Grossman RI, Arnold SE, Bilker WB, Gur RC. Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry. 2000;57:769-775.
43. Doty RL, Shaman P, Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984;32:489-502.
44. Hill SK, Ragland JD, Gur RO, Gur RE. Neuropsychological differences among empirically derived clinical subtypes of schizophrenia. Neuropsychology. 2001;15:492-501.
45. Censits DM, Ragland JD, Gur RC, Gur RE. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr Res. 1997;24:289-298.
46. Wechsier DA, Wechsler Adult Intelligence Scale, Revised (WMS-R), Manual. Cleveland, Ohio: Psychological Corp; 1981.
47. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test (CVLT) Manual. New York, NY: Psychological Corp; 1987.
48. Jones-Gotman M, Zatorre RJ, Cendes F, Olivier A, Andermann F, McMackin D, Staunton H, Siegel AM, Wieser HG. Contribution of medial versus lateral temporal-lobe structures to human odour identification. Brain. 1997;120:1845-1856.
49. Nakamura K, Kubota K. The primate temporal pole: its putative role in object recognition and memory. Behav Brain Res. 1996;77:53-77.
50. Mesulam MM, Mufson EJ. Insula of the old world monkey, I: architectonics in the insulo-orbito-temporal component of the paralimbic brain. J Comp Neurol. 1982;212:1-22.
51. Gur RE, Cowell P, Turetsky BI, Gallacher F, Cannon T, Bilker W, Gur RC. A follow-up magnetic resonance imaging study of schizophrenia: relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry. 1998;55:145-152.
52. Turetsky B, Cowell PE, Gur RC, Grossman RI, Shtasel DL, Gur RE. Frontal and temporal lobe brain volumes in schizophrenia: relationship to symptoms and clinical subtype. Arch Gen Psychiatry. 1995;52:1061-1070.
53. Gur RE, Petty RG, Turetsky BI, Gur RC. Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophr Res. 1996;21:1-12.
54. Brewer WJ, Pantelis C, Anderson V, Velakoulis D, Singh B, Copolov DL, McGorry PD. Stability of olfactory identification deficits in neuroleptic-naive patients with first-episode psychosis. Am J Psychiatry. 2001;158:107-115.
55. Brewer WJ, Edwards J, Anderson V, Robinson T, Pantelis C. Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biol Psychiatry. 1996;40:1021-1031.
56. Geddes J, Huws R, Pratt P. Olfactory acuity in the positive and negative syndromes of schizophrenia. Biol Psychiatry. 1991;29:774-778.
57. Stedman TJ, Clair AL. Neuropsychological, neurological and symptom correlates of impaired olfactory identification in schizophrenia. Schizophr Res. 1998;32:23-30.
58. Greer CA. Structural organization of the olfactory system. In: Getchell TV, Doty RL, Bartoshuk LM, Snow JB, eds. Smell and Taste in Health and Disease. New York, NY: Raven Press; 1991:65-81.
59. Cotman CW, Monaghan DT, Ottersen OP, Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathways. Trends Neurosci. 1987;10:273-279.
60. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 1999;33:523-533.
61. Ellison G. The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Brain Res Rev. 1995;20:250-267.
62. Corso TD, Sesma MA, Tenkova TI, Der TC, Wozniak DF, Farber NB, Olney JW. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res. 1997;752:1-14.
63. Arnold SE, Han LY, Moberg PJ, Turetsky BI, Gur RE, Trojanowski JQ, Hahn CG. Dysregulation of olfactory receptor neuron lineage in schizophrenia. Arch Gen Psychiatry. 2001;58:829-835.
64. Arnold SE, Rioux L, Han L-Y. Molecular markers of axon guidance and synaptogenesis in the olfactory bulb in schizophrenia [abstract]. Soc Neurosci Abstr. 2001;27:454-455.
65. Sherrard RM, Bower AJ. Acute neuronal and vascular changes following unilateral cerebellar pedunculotomy in the neonatal rat. J Anat. 1997;191:177-189.
66. Schwerdtfeger WK, Buhl EH, Germroth P. Disynaptic olfactory input to the hippocampus mediated by stellate cells in the entorhinal cortex. J Comp Neurol. 1990;292:163-177.
67. Turetsky BI, Moberg PJ, Owzar K, Johnson SA, Doty RL, Gur RE. Physiological impairment of olfactory stimulus processing in schizophrenia. Biol Psychiatry. 2003;53:403-411.